| Eric Joseph Ashman, MD | |
|
262 N Binkley St, Soldotna, AK 99669-7522 | |
| (907) 714-4090 | |
| (855) 712-3955 |
| Full Name | Eric Joseph Ashman |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 29 Years |
| Location | 262 N Binkley St, Soldotna, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639160849 | NPI | - | NPPES |
| 1417961137 | Other | MI | BCBSM - BRONSON |
| 1639160849 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 022817 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| South Peninsula Hospital | Homer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Peninsula General Hospital Inc | 4587552575 | 85 |
| Bronson Methodist Hospital | 0244148633 | 598 |
News Archive
A new study published in the journal IJIR: Your Sexual Medicine Journal in March 2020 reports the most common reasons why men stop their treatment for erectile dysfunction. The most common reasons were that the treatment did not work, cost too much, or had unacceptable side effects. Loss of interest in sexual relationships was another primary reason.
Drug discovery company SCYNEXIS, Inc. today announced that supportive data from a preclinical study of the Company's lead product candidate for hepatitis C (HCV), SCY-635, will be presented in a poster session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, MA, October 30-November 3, 2009.
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
The relative importance of genetic factors in tinnitus is low, according to new research from the Norwegian Institute of Public Health. This is the first large population-based study to measure the heritability of tinnitus.
"Drug makers, advocacy groups, biotechnology firms and insurance companies have ratcheted up efforts to offer their two cents - and in most cases much, much more - in influencing the health care legislation now working its way through Congress," The New York Times reports.
› Verified 6 days ago
| Entity Name | Central Peninsula General Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528062429 PECOS PAC ID: 4587552575 Enrollment ID: O20040310000598 |
News Archive
A new study published in the journal IJIR: Your Sexual Medicine Journal in March 2020 reports the most common reasons why men stop their treatment for erectile dysfunction. The most common reasons were that the treatment did not work, cost too much, or had unacceptable side effects. Loss of interest in sexual relationships was another primary reason.
Drug discovery company SCYNEXIS, Inc. today announced that supportive data from a preclinical study of the Company's lead product candidate for hepatitis C (HCV), SCY-635, will be presented in a poster session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, MA, October 30-November 3, 2009.
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
The relative importance of genetic factors in tinnitus is low, according to new research from the Norwegian Institute of Public Health. This is the first large population-based study to measure the heritability of tinnitus.
"Drug makers, advocacy groups, biotechnology firms and insurance companies have ratcheted up efforts to offer their two cents - and in most cases much, much more - in influencing the health care legislation now working its way through Congress," The New York Times reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Joseph Ashman, MD 250 Hospital Pl, Soldotna, AK 99669-7559 Ph: (907) 714-4038 | Eric Joseph Ashman, MD 262 N Binkley St, Soldotna, AK 99669-7522 Ph: (907) 714-4090 |
News Archive
A new study published in the journal IJIR: Your Sexual Medicine Journal in March 2020 reports the most common reasons why men stop their treatment for erectile dysfunction. The most common reasons were that the treatment did not work, cost too much, or had unacceptable side effects. Loss of interest in sexual relationships was another primary reason.
Drug discovery company SCYNEXIS, Inc. today announced that supportive data from a preclinical study of the Company's lead product candidate for hepatitis C (HCV), SCY-635, will be presented in a poster session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, MA, October 30-November 3, 2009.
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
The relative importance of genetic factors in tinnitus is low, according to new research from the Norwegian Institute of Public Health. This is the first large population-based study to measure the heritability of tinnitus.
"Drug makers, advocacy groups, biotechnology firms and insurance companies have ratcheted up efforts to offer their two cents - and in most cases much, much more - in influencing the health care legislation now working its way through Congress," The New York Times reports.
› Verified 6 days ago
Dr. Charles George Perkins, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 167 Warehouse Ave, Suite C, Soldotna, AK 99669 Phone: 907-262-6557 Fax: 907-262-6559 | |
Jeffrey S Magee, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 230 E Marydale Ave, Suite 2, Soldotna, AK 99669 Phone: 907-260-3691 Fax: 907-260-3697 | |
Kristen B Jessen, MD, PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 289 N Fireweed St Ste D, Soldotna, AK 99669 Phone: 907-714-4090 Fax: 907-262-2476 |